Can the fatal toxicity of antidepressant drugs be predicted with pharmacological and toxicological data?

Drug Safety

Volumn 18, Issue 5, 1998, Pages 369-381

  Buckley, Nicholas A ^a   McManus, Peter R ^b  

^a The Australian National University   (Australia)

^b Drug Utilization Sub Committee   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA ADRENERGIC RECEPTOR; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; BUTRIPTYLINE; CHOLINERGIC RECEPTOR; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; HISTAMINE RECEPTOR; IMIPRAMINE; IPRINDOLE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MUSCARINIC M1 RECEPTOR; NOMIFENSINE; NORADRENALIN; NORTRIPTYLINE; PAROXETINE; POTASSIUM CHANNEL; PROTRIPTYLINE; SEROTONIN; SERTRALINE; SODIUM CHANNEL; TRAZODONE; TRIMIPRAMINE; VILOXAZINE;

ANIMAL EXPERIMENT; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG FATALITY; DRUG INTOXICATION; DRUG POTENCY; DRUG SCREENING; DRUG SOLUBILITY; DRUG TOXICITY; HUMAN; LD 50; LETHALITY; LIPID SOLUBILITY; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PRESCRIPTION; PRIORITY JOURNAL; RECEPTOR AFFINITY; REGRESSION ANALYSIS; SEROTONIN UPTAKE; TOXICOLOGY; UNITED KINGDOM;

ANIMALS; ANTIDEPRESSIVE AGENTS; ENGLAND; HUMANS; LETHAL DOSE 50; OVERDOSE; POISONING; PRESCRIPTIONS, DRUG; RISK FACTORS; WALES;

EID: 0031950410     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199818050-00006     Document Type: Article

References (38)

1. Crome P. The toxicity of drugs used for suicide. Acta Psychiatr Scand 1993; Suppl. 371: 33-7
2. King LA, Moffat AC. A possible index of fatal drug toxicity in humans. Med Sci Law 1983; 23: 193-8
3. Cassidy S, Henry J. Fatal toxicity of antidepressant drugs in overdose. BMJ 1987; 295: 1021-4
4. Montgomery SA, Pinder RM. Do some antidepressants promote suicide? Psychopharmacology 1987; 92: 265-6
5. Henry JA, Antao CA. Suicide and fatal antidepressant poisoning. Eur J Med 1992; 1: 343-8
6. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221-4
7. Kapur S, Mieczkowski T, Mann J. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 1992; 268 (24): 3441-5
8. Kelleher MJ, Daly M, Kelleher MJA. The influence of antidepressants in overdose on the increased suicide rate in Ireland between 1971 and 1988. Br J Psychiatry 1992; 161: 625-8
9. Henry JA, Cassidy SL. Acute non-specific toxicity. In: Ballantyne B, Marrs T, Turner P, editors. General and applied toxicology I. Basingstoke, UK: MacMillan Press, 1993
10. Geigy Scientific Tables Volume 2. Introduction to statistics. Statistical tables. In: Lentner C, editor. Mathematical formulae. 8th ed. Basle, Switzerland: Ciba-Geigy Ltd, 1984
11. Pharmaceutical Index. Intercontinental Medical Statistics, UK 1983-92
12. World Health Organization. Anatomical therapeutic chemical (ATC) classification index including denned daily dose (DDDs) for plain substances. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1994
13. Richelson E, Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 1984; 104: 277-86
14. Richelson E. The pharmacology of antidepressants at the synapse: Focus on newer compounds. J Clin Psychiatry 1994; 55 Suppl. A: 34-9
15. Richelson E, Nelson A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther 1984; 230: 94-102
16. Lancaster SG, Gonzalez JP. Lofepramine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1989; 37 (2): 123-40
17. Squires RF, Saederup E. Mono N-aryl ethylenediamine and piperazine derivatives are GABAA receptor blockers: implications for psychiatry. Neurochem Res 1993; 18 (7): 787-93
18. Squires RF, Saederup E. Antidepressants and metabolites that block GABAA receptors coupled to 35S-t-butylbicyclophosphorothionate binding sites in rat brain. Brain Res 1988; 441 (1-2): 15-22
19. Cain CR, Hamilton TC, Norton J, et al. Relative lack of cardiotoxicity of paroxetine in animal models. Acta Psychiatr Scand 1989; 80 Suppl. 350: 27-30
20. 3H] imipramine in bovine adrenal medullary cells. J Pharmacol Exp Ther 1987; 243: 342-8
21. Perez-Vizcaino F, Carron R, Delpon E, et al. Effects of (S)-nafenodone, a new antidepressant, in isolated guinea-pig atrial and ventricular muscle fibres. Eur J Pharmacol 1991; 199: 43-50
22. Dollery CT, editor. Therapeutic drugs. Edinburgh: Churchill Livingstone, 1991
23. + exchange in human red cells by its sensitivity to tricyclic antidepressant drugs. Naunyn Schmiedebergs Arch Pharmacol 1988; 338 (3): 332-7
24. Budavari S, ONeil MJ, Smith A, et al., editors. The Merck index: an encyclopaedia of chemicals, drugs and biologicals. 12th ed. Rahway, NJ: Merck & Co, 1996
25. Moffat AC, editor. Clarkes isolation and identification of drugs. 2nd ed. London: The Pharmaceutical Press, 1986
26. Henry JA. Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Saf 1997; 16 (6): 374-90
27. Dwyer PS, Jones IF. Fatal self-poisoning in the UK and the paracetamol/dextropropoxyphene combination. Hum Toxicol 1984; 3: 145S-74S
28. Isaacson G, Redfors I, Wasserman D. et al. Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden. BMJ 1994; 309: 1546-9
29. Brasch H. Activators of sodium, calcium and potassium channels modulate the cardiac effects of quinidine in vitro. Pharmacol Toxicol 1995; 77: 346-51
30. Taboulet P, Michard F, Muszynski J, et al. Cardiovascular repercussions of seizures during cyclic antidepressant poisoning. J Toxicol Clin Toxicol 1993; 31: 531-51
31. Wedin GP, Oderda G, Klein-Schwartz W, et al. Relative toxicity of cyclic antidepressants. Ann Emerg Med 1986; 14: 797-804
32. Buckley NA, Dawson AH, Whyte IM, et al. Greater toxicity in overdose of dothiepin than other tricyclic antidepressants Lancet 1994; 343: 159-62
33. Buckley NA, McManus P. Fatal toxicity of drugs used in the treatment of psychotic illness. Br J Psychiatry 1998. In press
34. Roose SP, Glassman AH. Antidepressant choice in the patient with cardiac disease. Lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies. J Clin Psychiatry 1994; 55 Suppl. A: 83-7
35. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995; 310: 1433-8
36. Owen A. Nearly a third of deaths related to poisoning [letter]. BMJ 1994; 308: 915
37. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995; 310: 215-8
38. Nordentoft M, Breum L, Munck LK, et al. High mortality by natural and unnatural causes: a 10 year follow up study of patients admitted to a poisoning treatment centre after suicide attempts. BMJ 1993; 306: 1637-41